Order results by:
| Issue | Title | |
| Vol 8, No 2 (2015) | SYSTEMATIC LITERATURE REVIEW ON CLINICAL EFFICACY AND SAFETY OF ALOGLIPTIN IN COMPARISON WITH VILDAGLIPTIN, LINAGLIPTIN, SAXAGLIPTIN AND SITAGLIPTIN IN ADULT PATIENTS WITH TYPE 2 DIABETES MELLITUS | Abstract similar documents |
| Georgii Rubenovich Khachatryan, Vladislav Sergeevich Dombrovskii | ||
| "... plus metformin achieved HbA1c <7% more frequently than those treated with saxagliptin plus metformin ..." | ||
| Vol 11, No 3 (2018) | What is the role of antineoplastic drug safety in reimbursement decision making? | Abstract similar documents |
| A. S. Kolbin, A. A. Kurylev | ||
| "... (Aes). The question whether drug safety is taken into consideration by decision makers is still open ..." | ||
| Vol 9, No 3 (2016) | EFFICACY AND SAFETY OF THE ORAL ANTICOAGULANTS IN THE MANAGEMENT OF VENOUS THROMBOEMBOLISM: INDIRECT COMPARISON | Abstract similar documents |
| V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, D. V. Frolov, E. A. Ponomarev, A. S. Maslakov | ||
| "... Objective. The aim was to perform an indirect comparisons of the effectiveness and safety of new ..." | ||
| Vol 7, No 1 (2014) | EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE | Abstract similar documents |
| M. N. Kostyleva, Yu. B. Belousov, A. N. Gratsianskaya, S. S. Postnikov | ||
| "... the present review is devoted to an actual problem of safety of pharmacotherapy in clinical ..." | ||
| Vol 10, No 2 (2017) | ECONOMIC ASSESSMENT OF THE EFFECTIVENESS AND SAFETY OF THE COMMONLY PRACTICED PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS (BASED ON AN EARLIER EPIDEMIOLOGICAL SURVEY OF MULTIDISCIPLINARY HOSPITALS) | Abstract similar documents |
| Yu. M. Gomon, A. S. Kolbin, S. V. Sidorenko, A. M. Kuzhel’, A. V. Repina, Yu. V. Lobzin, Yu. E. Balykina | ||
| "... to compare the effectiveness and safety of the commonly used PAP with that recommended by the clinical ..." | ||
| Vol 11, No 3 (2018) | Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review | Abstract similar documents |
| D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, K. I. Polyakova, A. G. Fisun, K. A. Kokushkin | ||
| "... Aim: To analyze the efficacy, safety and pharmacoeconomic aspects of using ocrelizumab in adult ..." | ||
| Vol 8, No 1 (2015) | PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION | Abstract similar documents |
| M. V. Avxentyeva, N. A. Avxentyev, M. Yu. Frolov, E. V. Derkach | ||
| "... renal transplantation: everolimus plus reducedexposure cyclosporine and mycophenolic acid plus standard ..." | ||
| Vol 10, No 1 (2017) | CLINICAL AND ECONOMIC EVALUATION OF ERIBULIN EFFECTIVENESS IN SOFT TISSUE SARCOMA: RESULTS OF META-ANALYSIS | Abstract similar documents |
| P. V. Мazin, I. V. Sheshunov, N. K. Mazina, E. M. Markova | ||
| "... to the results of two multicenter, randomized phase III clinical studies, on effectiveness and safety ..." | ||
| Vol 9, No 3 (2016) | Эффективность и безопасность пероральных антикоагулянтов при венозных тромбоэмболических осложнениях: непрямые сравнения | Abstract similar documents |
| "... Цель: Сравнительный анализ эффективности и безопасности новых пероральных антикоагулянтов ..." | ||
| Vol 9, No 3 (2016) | COPAYMENTS OF THE CITIZENS IN HEALTHCARE SYSTEM: INTERNATIONAL PRACTICE | Abstract similar documents |
| A. P. Tatarinov, D. V. Lukyantseva, L. S. Melnikova, V. V. Omelyanovskii | ||
| "... здравоохранения, характеристика систем здравоохранения раз- личных стран мира, гарантии безопасности. Статья ..." | ||
| Vol 7, No 1 (2014) | PHARMACOEPIDEMIOLOGY: FROM THEORY TO PRACTICE | Abstract similar documents |
| S. A. Rachina, R. S. Kozlov, Yu. A. Belkova | ||
| "... to improve efficacy and safety of pharmacotherapy. Despite its relatively short history pharmacoepidemiology ..." | ||
| Vol 5, No 3 (2012) | PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERS | Abstract similar documents |
| M. V. Protsenko | ||
| "... and can be claimed dominant. Futhermore Azarga in comparison with Dorzopt plus is cost-effective drug ..." | ||
| Vol 6, No 4 (2013) | Фармакоэкономический анализ использования лираглутида в составе комбинированной терапии в лечении сахарного диабета 2-го типа | Abstract similar documents |
| A. Yu. Kulikov, I. V. Novikov | ||
| "... . rosiglitazone (as add-on to metformin). From them data on clinical effectiveness in form of impact on HbA1(c ..." | ||
| Vol 6, No 2 (2013) | FIRST RUSSIAN TYPE 2 DIABETES MELLITUS SIMULATION MODEL WITH DISCREET EVENTS MODELING. HEALTH-ECONOMIC ANALYSIS | Abstract similar documents |
| A. S. Kolbin, O. K. Khmelnitskiy, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, E. P. Kolpak, M. V. Bure | ||
| "... ’s effectiveness were incorporated into the model as its ability to modify input parameters (HbA1c, lipids, etc ..." | ||
| Vol 6, No 4 (2013) | Using indirect comparisons in pharmacoeconomic examination | Abstract similar documents |
| Yu. E. Balykina, A. S. Kolbin | ||
| "... новой медицинской технологии, а сравнение ее с подобными лечебными подходами, то есть – сравнительные ..." | ||
| Vol 8, No 4 (2015) | CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS | Abstract similar documents |
| E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva | ||
| "... between the drugs in terms of clinical efficacy and safety and this hypothesis is grounded on the results ..." | ||
| Vol 6, No 2 (2013) | COST-EFFECTIVENESS ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS | Abstract similar documents |
| R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov | ||
| "... посвящено применению нило- тиниба по новому показанию в сравнении с применением имати- ниба в первой линии ..." | ||
| Vol 6, No 3 (2013) | COST-UTILITY ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS | Abstract similar documents |
| R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov | ||
| "... экономически-эффективным, с точки зрения анализа «затраты-эффективность», по сравнению с использованием ..." | ||
| Vol 5, No 3 (2012) | CLINICAL AND ECONOMIC BENEFITS OF HUMAN INSULIN ANALOGUESUSE | Abstract similar documents |
| E. E. Arinina, M. A. Rashyd | ||
| "... /аспарт в сравнении с НПХ/человеческими инсулинами для лечения больных сахарным диабетом 1-го типа и ..." | ||
| Vol 9, No 3 (2016) | HEALTH ECONOMIC ASSESSMENT OF ANTIRHEUMATIC DRUGS IN PATIENTS WITH REUMATHOID ARTHRITIS PROGRESSED AFTER METOTREXATE | Abstract similar documents |
| A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, Yu. E. Balykina | ||
| "... progression on methotrexate showed that evaluated regimens do not differs in terms of effectiveness and safety ..." | ||
| Vol 9, No 4 (2016) | COMPARISON OF RECOMMENDED SCREENING PROGRAMS IN THE UNITED STATES, CANADA, THE NETHERLANDS AND GERMANY | Abstract similar documents |
| V. S. Dombrovskiy, G. R. Khachatryan | ||
| "... В данной публикации представлено сравнение рекомендаций скрининговых программ и профилактических ..." | ||
| Vol 9, No 1 (2016) | COMPARATIVE CLINICAL AND ECONOMIC ANALYSIS OF THE INTENSIFICATION THERAPY IN PATIENTS WITH UNCONTROLLED DIABETES TYPE 2 USING BASAL INSULIN OR DAPAGLIFLOZIN | Abstract similar documents |
| V. I. Petrov, S. V. Nedogoda, M. Yu. Frolov, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova, V. Yu. Khripaeva | ||
| "... его в терапию у пациентов с недостаточным гликемическим контролем в сравнении с базальными инсулинами ..." | ||
| Vol 10, No 1 (2017) | EVALUATION OF DRUG THERAPY IN PROGRESSING DIFFERENTIATED THYROID CANCER REFRACTORY TO RADIOACTIVE IODINE IN PATIENTS RESIDING IN THE RUSSIAN FEDERATION : PHARMACOECONOMIC ASPECTS | Abstract similar documents |
| M. Yu. Frolov, V. A. Rogov | ||
| "... agent (with a manageable safety profile) to be used in monotherapy of DTC refractory to radioactive ..." | ||
| Vol 9, No 3 (2016) | CLINICAL AND ECONOMIC EVALUATION OF LACOSAMIDE IN PATIENTS WITH PARTIAL EPILEPSY | Abstract similar documents |
| E. A. Pyadushkina, M. Yu. Frolov | ||
| "... into consideration the commeasurable efficacy and safety, the economic advantages of Lacosamide over Perampanel are 1 ..." | ||
| Vol 11, No 1 (2018) | Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia | Abstract similar documents |
| I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina | ||
| "... reproduced AA at the level of ≥70% (instead of the reference AA similar in efficacy and safety) to keep ..." | ||
| Vol 11, No 2 (2018) | Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia | Abstract similar documents |
| I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina | ||
| "... at the level of ≥70% (instead of the reference AA similar in efficacy and safety) to keep the treatment ..." | ||
| Vol 9, No 2 (2016) | METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY | Abstract similar documents |
| N. A. Avxentyev, E. V. Derkach, E. A. Pyadushkina, M. D. Ter-Ovanesov | ||
| "... препарата — регорафениба. Целью настоящего исследования является сравнение стоимости применения данных ..." | ||
| Vol 9, No 1 (2016) | PHARMACOECONOMIC SUBSTANTIATION OF APPLICATION OF GENETICALLY ENGINEERED BIOLOGICAL AGENTS IN OUT-PATIENT CONDITIONS | Abstract similar documents |
| O. Yu. Korennova, L. V. Shukil', S. N. Mal'tsev, I. A. Klinyshkov, N. M. Leganova, E. A. Turusheva, T. V. Kropotina | ||
| "... of patients that testifies to identity of parameters of safety of carrying out of genetically engineered ..." | ||
| Vol 10, No 3 (2017) | Initiation and intensification of insulin therapy in patients with type 2 diabetes mellitus: a budget impact analysis | Abstract similar documents |
| E. V. Biryukova, V. I. Ignat’eva | ||
| "... use, all these regimens have the similar efficacy and safety; therefore, when choosing a therapeutic ..." | ||
| Vol 9, No 2 (2016) | PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA | Abstract similar documents |
| N. A. Avxentyev, M. Yu. Frolov | ||
| "... сравнению со вторым наилучшим вариантом), расходы всей системы здравоохранения — 5,7 млрд руб. (экономия ..." | ||
| Vol 9, No 1 (2016) | SYSTEMATIC REVIEW OF PENTAGLOBIN EFFICACY IN PREVENTING MORTALITY IN NEWBORNS AND OLDER CHILDREN WITH BACTERIAL INFECTIONS AND SEPSIS | Abstract similar documents |
| V. K. Fedyaeva, O. Yu. Rebrova | ||
| "... ., поиск был повторен в октябре 2015 г. Были выполнены мета-анализы и непрямое сравнение по критерию ..." | ||
| Vol 11, No 1 (2018) | CYP2D6 genotyping in the daily routine of a psychiatric hospital – pharmacoeconomic evaluation | Abstract similar documents |
| A. A. Kurylev, B. V. Andreev, A. S. Kolbin, O. V. Limankin | ||
| "... Today, pharmacogenetic tests are commonly used to improve the efficacy and safety of antipsychotic ..." | ||
| Vol 6, No 4 (2013) | Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital | Abstract similar documents |
| A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina | ||
| "... натрия в сравнении с другими низкомолекулярными гепаринами у пациентов с высоким риском развития венозных ..." | ||
| Vol 7, No 4 (2014) | ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS | Abstract similar documents |
| M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentieva | ||
| "... standards; monitoring of quality, efficacy and safety of drugs circulating on the Russian market ..." | ||
| Vol 9, No 1 (2016) | PHARMACOECONOMIC STUDY OF LENVIMA (LENVATINIB) IN ADVANCED PROGRESSIVE RADIO IODINE REFRACTORY DIFFERENTIATED THYROID CANCER IN THE RUSSIAN FEDERATION | Abstract similar documents |
| M. Yu. Frolov, V. A. Rogov | ||
| "... управляемым профилем безопасности для монотерапии дифференцированного рака щитовидной железы, рефрактерного к ..." | ||
| Vol 8, No 2 (2015) | ASSESSMENT OF ECONOMIC EFFICIENCY OF APPLICATION OF RALTEGRAVIR BY PATIENTS WITHOUT EXPERIENCE OF TYPE 1 HIV INFECTION THERAPY IN RUSSIA | Abstract similar documents |
| Elamin H. Elbasha, Elena Aleksandrovna Pyadushkina, Maria Vladimirovna Avxentyeva, Alexander Gennadievich Tolkushin, Maxim Yurievich Frolov | ||
| "... антиретровирусной терапии по сравнению со схемами на основе препаратов из группы ингибиторов протеазы у взрослых ..." | ||
| Vol 9, No 1 (2016) | COST-EFFECTIVENESS ANALYSIS OF BRENTUXIMAB VEDOTIN IN ADULTS WITH RELAPSED OR REFRACTORY HODGKIN’S LYMPHOMA | Abstract similar documents |
| G. R. Khachatryan, D. V. Fedyaev, M. V. Avxentyeva, V. S. Dombrovskiy | ||
| "... втором этапе произведено сравнение ICER, рассчитанного по единой методике для БВ при ЛХ и других ..." | ||
| Vol 11, No 1 (2018) | . | Abstract similar documents |
| I. A. Vilyum, . ., . ., . . | ||
| "... применением АА являлись более ресурсоемкими медицинскими технологиями в сравнении с КА для бюджета ..." | ||
| Vol 7, No 2 (2014) | PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD | Abstract similar documents |
| A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin | ||
| "... , благоприят- ный профиль токсичности, по сравнению с существующими стан- дартными режимами терапии, объясняет ..." | ||
| Vol 8, No 1 (2015) | BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD | Abstract similar documents |
| A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina | ||
| "... использование препарата бендамустин при сравнении со стратегией бортезомиба является более предпочтительной ..." | ||
| Vol 5, No 1 (2012) | VI CONGRESS WITH INTERNATIONAL PARTICIPATION «DEVELOPMENT OF PHARMACOECONOMICS AND PHARMACOEPIDEMIOLOGY IN RUSSIAN FEDERATION» | Abstract similar documents |
| "... эффективны и безопасны по сравнению с применяющимися в клинической практике амиодароном и лидокаи- ном ..." | ||
| Vol 7, No 4 (2014) | АNALYSIS OF PSYCHOTROPIC DRUG CONSUPTION FOR SCHIZOPHRENIA TREATMENT IN DIFFERENT TYPE HOSPITALS | Abstract similar documents |
| P. S. Nosova, O. V. Reshetko | ||
| "... выражаться различными способами. Однако сравнение данных о потреблении медикаментов в стоимостном выражении ..." | ||
| Vol 5, No 3 (2012) | PHARMACOECONOMIC EVALUATION OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON DIALYSIS WITH CINACALCET | Abstract similar documents |
| R. I. Yagudina, V. G. Serpik | ||
| "... в настоящем фармакоэкономическом исследовании проведено сравнение стандартной фармакотерапии ..." | ||
| Vol 6, No 2 (2013) | PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH CARBONIC ANHYDRASE INHIBITORS | Abstract similar documents |
| A. Yu. Kulikov, V. G. Serpik | ||
| "... сравнении с препаратом Трусопт, Азопт также предоставляет экономию денежных средств, демонстрируя ..." | ||
| Vol 5, No 2 (2012) | PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH COMBINATIONS OF PROSTAGLANDIN ANALOGUES AND BETA-BLOCKERS | Abstract similar documents |
| A. Yu. Kulikov, V. G. Serpikov | ||
| "... сравнении с препаратом Ксалаком, Дуотрав предоставляет экономию денежных средств в размере 1 721 руб. на ..." | ||
| Vol 6, No 3 (2013) | PHARMACOECONOMIC ANALYSIS OF NEUROPROTECTIVE DRUGS IN THE TREATMENT OF ACUTE DISORDERS OF CEREBRAL CIRCULATION | Abstract similar documents |
| A. Yu. Kulikov, I. Yu. Zinchuk | ||
| "... В рамках данного фармакоэкономического исследования было проведено сравнение применения плацебо и ..." | ||
| Vol 7, No 1 (2014) | ROLE OF RANDOMIZED TRIALS IN PHARMACOEPIDEMIOLOGY | Abstract similar documents |
| T. L. Galankin, A. S. Kolbin | ||
| "... - следственных связей (например, влияние ремней безопасности на смертность в дорожно-транспортных происшествиях ..." | ||
| Vol 7, No 1 (2014) | CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT | Abstract similar documents |
| I. I. Shteynberg, S. K. Zyryanov, Yu. B. Belousov | ||
| "... исследования. При сравнении исследуемых пре- паратов между собой рассчитывался коэффициент «затраты ..." | ||
| Vol 7, No 3 (2014) | PHARMACOECONOMIC ANALYSIS OF THE USE OF OXALIPLATIN CHEMOTHERAPY FOR COLORECTAL CANCER.REAL (ACTUAL) CLINICAL PRACTICE DATA | Abstract similar documents |
| A. V. Pavlysh, A. S. Kolbin, A. R. Kasimova | ||
| "... ,1%. Коэффициенты ICER для препарата элоксатин составили 8801 и 18162 в сравнении с препаратами экзорум и платикад ..." | ||
| 1 - 50 of 158 Items | 1 2 3 4 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
